Orchestra BioMed’s (OBIO) “Buy” Rating Reiterated at HC Wainwright
Orchestra BioMed (NASDAQ:OBIO – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $14.00 target price on the stock. HC Wainwright’s price target suggests a potential upside of 250.00% from the stock’s current price. Several other […]
Orchestra BioMed (NASDAQ:OBIO – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $14.00 target price on the stock. HC Wainwright’s price target suggests a potential upside of 250.00% from the stock’s current price. Several other […]
